Jean Coutu Group (PJC) (A)

PJC.A-T

Analysis and Opinions about PJC.A-T

Signal
Opinion
Expert
SELL STRENGTH
SELL STRENGTH
April 27, 2017

He does not hold because of valuation and that the sector is one that he does not need to be in. If you are sitting on gains, there is nothing wrong with taking them. It may go up because of share buybacks, however.

Show full opinionHide full opinion

He does not hold because of valuation and that the sector is one that he does not need to be in. If you are sitting on gains, there is nothing wrong with taking them. It may go up because of share buybacks, however.

BUY
BUY
August 19, 2016

Operates pharmacies primarily in Québec. He likes the space and it does meet his criteria. Their cash ROE is just shy of 30%, and their cash ROE/PE metric is about 2.67. Based on those metrics, this would be a good one to own.

Show full opinionHide full opinion

Operates pharmacies primarily in Québec. He likes the space and it does meet his criteria. Their cash ROE is just shy of 30%, and their cash ROE/PE metric is about 2.67. Based on those metrics, this would be a good one to own.

DON'T BUY
DON'T BUY
March 15, 2016

Because of the Québec base and lack of growth, he wouldn’t go to this.

Show full opinionHide full opinion

Because of the Québec base and lack of growth, he wouldn’t go to this.

COMMENT
COMMENT
January 19, 2016

In retail, he would be looking at off-price retail or convenience. Alimentation Couch-Tard (ATD.B-T) is one. Jean Coutu is down about 10%-11% from its highs and is underperforming the group. Likes the consumer, but wants to own one that has a bit of a tailwind.

Show full opinionHide full opinion

In retail, he would be looking at off-price retail or convenience. Alimentation Couch-Tard (ATD.B-T) is one. Jean Coutu is down about 10%-11% from its highs and is underperforming the group. Likes the consumer, but wants to own one that has a bit of a tailwind.

DON'T BUY
DON'T BUY
December 21, 2015

He does not know the seasonality on this one. The chart is not so good. The stock is in a downward trend and may be trying to find support above $18. It is underperforming the market, below the 20 day moving average, and the momentum indicators are on the downside. There is insufficient reason to buy at these levels. Watch it to see if it bottoms.

Show full opinionHide full opinion

He does not know the seasonality on this one. The chart is not so good. The stock is in a downward trend and may be trying to find support above $18. It is underperforming the market, below the 20 day moving average, and the momentum indicators are on the downside. There is insufficient reason to buy at these levels. Watch it to see if it bottoms.

COMMENT
COMMENT
December 4, 2015

Governments are getting really difficult to deal with if you are a pharmacy. This is a good space because healthcare is a growing area, but there are these little headwinds that can give you pause.

Show full opinionHide full opinion

Governments are getting really difficult to deal with if you are a pharmacy. This is a good space because healthcare is a growing area, but there are these little headwinds that can give you pause.

COMMENT
COMMENT
September 4, 2015

The seasonality on this tends to positive in the summer. The stock tends to peak out around the middle of September, so we are getting close to the end of a period of seasonal strength. Technically the trend is down, but seems to be trying to form a base. Trading below its 20 day moving average which is not so good. Short-term momentum indicators are slightly positive. The time to take profits is probably from the middle to the end of September.

Show full opinionHide full opinion

The seasonality on this tends to positive in the summer. The stock tends to peak out around the middle of September, so we are getting close to the end of a period of seasonal strength. Technically the trend is down, but seems to be trying to form a base. Trading below its 20 day moving average which is not so good. Short-term momentum indicators are slightly positive. The time to take profits is probably from the middle to the end of September.

WATCH
WATCH
August 24, 2015

In the downturn this stock most definitely took out its past lows. Had been making a higher lows and higher highs and the last low of around $24 definitely broke. It may be starting to put in a base, but he would like to see it bounce around a bit and find support at around $19 before buying.

Show full opinionHide full opinion

In the downturn this stock most definitely took out its past lows. Had been making a higher lows and higher highs and the last low of around $24 definitely broke. It may be starting to put in a base, but he would like to see it bounce around a bit and find support at around $19 before buying.

WATCH
WATCH
August 17, 2015

There was some news recently on prescriptions in Quebec, similar to Shoppers a couple of years ago. He likes the pharmacy business, however.

Show full opinionHide full opinion

There was some news recently on prescriptions in Quebec, similar to Shoppers a couple of years ago. He likes the pharmacy business, however.

BUY
BUY
August 14, 2015

This has been under pressure because of declining generic drug prices. Pays a decent dividend and, on a valuation basis, this is a good entry point. Likes their franchise model, which means their CapX is much lower than if they were corporately owned. About 95% of the stores are franchised, so there is a reoccurring revenue stream with not a lot of capital tied up.

Show full opinionHide full opinion

This has been under pressure because of declining generic drug prices. Pays a decent dividend and, on a valuation basis, this is a good entry point. Likes their franchise model, which means their CapX is much lower than if they were corporately owned. About 95% of the stores are franchised, so there is a reoccurring revenue stream with not a lot of capital tied up.

COMMENT
COMMENT
May 12, 2015

Kind of a Shoppers Drug Mart of Québec, and has a dominant position there. Stumbled very badly a few years ago making US acquisitions, but are now doing better. Has pretty much has recovered from its woes of the past. This is worth a look.

Show full opinionHide full opinion

Kind of a Shoppers Drug Mart of Québec, and has a dominant position there. Stumbled very badly a few years ago making US acquisitions, but are now doing better. Has pretty much has recovered from its woes of the past. This is worth a look.

COMMENT
COMMENT
May 8, 2015

This stock has done fabulously well. They made all of these acquisitions. The stock has, fairly far, outrun its FMV because of their tremendous momentum with acquisitions. He is not surprised that the stock is setting back. It is historically high and also high against all of his parameters too. It is expensive.

Show full opinionHide full opinion

This stock has done fabulously well. They made all of these acquisitions. The stock has, fairly far, outrun its FMV because of their tremendous momentum with acquisitions. He is not surprised that the stock is setting back. It is historically high and also high against all of his parameters too. It is expensive.

COMMENT
COMMENT
March 18, 2015

Alimenation Couche-Tard (ATD.B-T) or Jean Coutu (PJC.A-T)? He prefers Alimenation Couche-Tard.

Show full opinionHide full opinion

Alimenation Couche-Tard (ATD.B-T) or Jean Coutu (PJC.A-T)? He prefers Alimenation Couche-Tard.

HOLD
HOLD
May 6, 2014

This has done quite well. Pharma business is attractive, but there is some sort of takeover element in this name. A growth story and very well managed. She would wait for a pullback.

Show full opinionHide full opinion

This has done quite well. Pharma business is attractive, but there is some sort of takeover element in this name. A growth story and very well managed. She would wait for a pullback.

BUY WEAKNESS
BUY WEAKNESS
May 5, 2014

Thinks they are driven by money coming out of SC-T when it was acquired. They increased the dividend and this is driving the stock. They are now more shareholder friendly. Doesn’t think it will be sold in our lifetime.

Show full opinionHide full opinion

Thinks they are driven by money coming out of SC-T when it was acquired. They increased the dividend and this is driving the stock. They are now more shareholder friendly. Doesn’t think it will be sold in our lifetime.

BUY WEAKNESS
BUY WEAKNESS
March 5, 2014

There is consolidation in this industry. The family would have to want to sell in the case of being acquired. Likes the pharma industry, which is more attractive than grocery. The chart is not that attractive so she would wait for it to pull back a little bit.

Show full opinionHide full opinion

There is consolidation in this industry. The family would have to want to sell in the case of being acquired. Likes the pharma industry, which is more attractive than grocery. The chart is not that attractive so she would wait for it to pull back a little bit.

DON'T BUY
DON'T BUY
November 26, 2013

Recently did a big dividend distribution. Looks like a decent play. Valuation looks a little bit stretched. If you want a play in this space, he would look at Loblaw’s (L-T) or Empire (EMP.A-T), which is very interesting if you look a year out from now.

Show full opinionHide full opinion

Recently did a big dividend distribution. Looks like a decent play. Valuation looks a little bit stretched. If you want a play in this space, he would look at Loblaw’s (L-T) or Empire (EMP.A-T), which is very interesting if you look a year out from now.

BUY WEAKNESS
BUY WEAKNESS
November 18, 2013

Growth by acquisition type of name, but we are into a zone of resistance. Will struggle in this range. No huge upside. Above $17 you could hold it.

Show full opinionHide full opinion

Growth by acquisition type of name, but we are into a zone of resistance. Will struggle in this range. No huge upside. Above $17 you could hold it.

BUY
BUY
November 1, 2013

(Market call minute.) A lots of speculation around this in terms of whether Metro (MRU-T) is going to buy it. Trades at a rich multiple but is executing quite well and generating a ton of free cash flow. Very, very safe dividend.

Show full opinionHide full opinion

(Market call minute.) A lots of speculation around this in terms of whether Metro (MRU-T) is going to buy it. Trades at a rich multiple but is executing quite well and generating a ton of free cash flow. Very, very safe dividend.

COMMENT
COMMENT
October 23, 2013

Recently made an offer to buy back shares at $18.50 and if you own, he would be tempted to take it. Also paying a special dividend. He would expect that after the dividend and the buy back the stock will trade a little bit lower. There is a lot of competition coming, especially in the front end of the store. A little expensive right now but could be very interesting a few dollars down.

Show full opinionHide full opinion

Recently made an offer to buy back shares at $18.50 and if you own, he would be tempted to take it. Also paying a special dividend. He would expect that after the dividend and the buy back the stock will trade a little bit lower. There is a lot of competition coming, especially in the front end of the store. A little expensive right now but could be very interesting a few dollars down.

WAIT
WAIT
October 9, 2013

It is richly valued because of the Shoppers’ takeover. Would wait for the stock price to fall back.

Show full opinionHide full opinion

It is richly valued because of the Shoppers’ takeover. Would wait for the stock price to fall back.

BUY
BUY
October 7, 2013

One of the few companies who have invested in the drug store space. Was going to move his money from Shoppers. But if you are buying it for them to be taken out then you could be waiting a long time. A great space and there is room to grow the dividend.

Show full opinionHide full opinion

One of the few companies who have invested in the drug store space. Was going to move his money from Shoppers. But if you are buying it for them to be taken out then you could be waiting a long time. A great space and there is room to grow the dividend.

WATCH
WATCH
October 1, 2013

The longer-term trend is with you. The stock periodically does a little bit of consolidation. Chart shows higher highs and higher lows, which is a healthy profile. Right now it is in a consolidation phase and if it got to the trend line at about $17, it would be a buying opportunity. Great-looking chart.

Show full opinionHide full opinion

The longer-term trend is with you. The stock periodically does a little bit of consolidation. Chart shows higher highs and higher lows, which is a healthy profile. Right now it is in a consolidation phase and if it got to the trend line at about $17, it would be a buying opportunity. Great-looking chart.

WATCH
WATCH
September 16, 2013

Potential take out candidate. It would be Metro, most likely. A very well run company. With shippers taken out it will be the only guy left. The take out premium has already been priced in. He would wait. Doesn’t like the risk / reward ratio. It would make a lot of sense if PJC took out someone else.

Show full opinionHide full opinion

Potential take out candidate. It would be Metro, most likely. A very well run company. With shippers taken out it will be the only guy left. The take out premium has already been priced in. He would wait. Doesn’t like the risk / reward ratio. It would make a lot of sense if PJC took out someone else.

BUY WEAKNESS
BUY WEAKNESS
September 11, 2013

What is interesting about this is that they sold Rite Ade recently so they have about $500 million in cash. Then you have the Loblaw’s (L-T) and Sobeys’s, Safeway. Metro is saying they could do something maybe. He thinks it is possible that Metro can buy this company. He would not want to buy something just for that though. This one is on his watch list for $17.50.

Show full opinionHide full opinion

What is interesting about this is that they sold Rite Ade recently so they have about $500 million in cash. Then you have the Loblaw’s (L-T) and Sobeys’s, Safeway. Metro is saying they could do something maybe. He thinks it is possible that Metro can buy this company. He would not want to buy something just for that though. This one is on his watch list for $17.50.

WATCH
WATCH
August 20, 2013

Believes it is an overcrowded trade. Don’t buy at the top of the growth channel. The trend is still up, but he would not be too excited about it.

Show full opinionHide full opinion

Believes it is an overcrowded trade. Don’t buy at the top of the growth channel. The trend is still up, but he would not be too excited about it.

COMMENT
COMMENT
August 12, 2013

This one had a big jump on the news of the Shoppers takeover. Not sure how much more upside there is on this. Getting to the point where he is going to have to start thinking about selling. They still own a lot of shares in Rite Aid (RAD-N).

Show full opinionHide full opinion

This one had a big jump on the news of the Shoppers takeover. Not sure how much more upside there is on this. Getting to the point where he is going to have to start thinking about selling. They still own a lot of shares in Rite Aid (RAD-N).

PAST TOP PICK
PAST TOP PICK
June 24, 2013

(A Top Pick June 18/12. Up 11.67%.) An okay company but he couldn’t see anything for them to acquire so he sold his holdings.

Show full opinionHide full opinion

(A Top Pick June 18/12. Up 11.67%.) An okay company but he couldn’t see anything for them to acquire so he sold his holdings.

PAST TOP PICK
PAST TOP PICK
May 8, 2013

(Top Pick May 14/12, Up 17.90%) Took profits and moved on to Weston’s. He is interested again but the volume has to be there. Well run business.

Show full opinionHide full opinion

(Top Pick May 14/12, Up 17.90%) Took profits and moved on to Weston’s. He is interested again but the volume has to be there. Well run business.

PAST TOP PICK
PAST TOP PICK
April 3, 2013

(A Top Pick May 7/12. Up 6.2%.) He thought there would be more action in terms of expansion. Have put up decent earnings but there really hasn’t been a big story. Has not been adding to his position.

Show full opinionHide full opinion

(A Top Pick May 7/12. Up 6.2%.) He thought there would be more action in terms of expansion. Have put up decent earnings but there really hasn’t been a big story. Has not been adding to his position.

Showing 1 to 30 of 204 entries

Jean Coutu Group (PJC) (A)(PJC.A-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Jean Coutu Group (PJC) (A) is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Jean Coutu Group (PJC) (A)(PJC.A-T) Frequently Asked Questions

What is Jean Coutu Group (PJC) (A) stock symbol?

Jean Coutu Group (PJC) (A) is a OTC stock, trading under the symbol PJC.A-T on the (). It is usually referred to as or PJC.A-T

Is Jean Coutu Group (PJC) (A) a buy or a sell?

In the last year, there was no coverage of Jean Coutu Group (PJC) (A) published on Stockchase.

Is Jean Coutu Group (PJC) (A) a good investment or a top pick?

Jean Coutu Group (PJC) (A) was recommended as a Top Pick by Mohsin Bashir on 2017-04-27. Read the latest stock experts ratings for Jean Coutu Group (PJC) (A).

Why is Jean Coutu Group (PJC) (A) stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Jean Coutu Group (PJC) (A) worth watching?

0 stock analysts on Stockchase covered Jean Coutu Group (PJC) (A) In the last year. It is a trending stock that is worth watching.

What is Jean Coutu Group (PJC) (A) stock price?

On , Jean Coutu Group (PJC) (A) (PJC.A-T) stock closed at a price of $.